Evidence map›Paper›PMID 35191841›Full record

ArticleJMIR formative research2022

How Vaccine Ambivalence Can Lead People Who Inject Drugs to Decline COVID-19 Vaccination and Ways This Can Be Addressed: Qualitative Study.

Ian David Aronson, Alex S Bennett, Mary-Andrée Ardouin-Guerrier, German Rivera-Castellar, Brent Gibson, Samantha Santoscoy, Brittney Vargas-Estrella

Abstract read
In one paragraph

Article in JMIR formative research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ian David Aronson *Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY, United States.ORCID https://orcid.org/0000-0002-2238-3810
Alex S BennettDepartment of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY, United States.ORCID https://orcid.org/0000-0001-6986-9925
Mary-Andrée Ardouin-GuerrierDepartment of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY, United States.ORCID https://orcid.org/0000-0002-6197-2589
German Rivera-CastellarDepartment of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY, United States.ORCID https://orcid.org/0000-0001-9940-4547
Brent GibsonNew York Harm Reduction Educators, New York, NY, United States.ORCID https://orcid.org/0000-0002-3575-8431
Samantha SantoscoyNew York Harm Reduction Educators, New York, NY, United States.ORCID https://orcid.org/0000-0001-5320-6828
Brittney Vargas-EstrellaNew York Harm Reduction Educators, New York, NY, United States.ORCID https://orcid.org/0000-0002-2495-8606

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
Treatment Development & Evaluation CoreP30DA029926 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2011 to 2026
$21.5M
Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject DrugsR01DA054990 · NIDA · NEW YORK UNIVERSITY · PI ARONSON, IAN DAVID · 2021 to 2024
$2.4M
Social Determinants of HIVT32MH128395 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gina Maria Wingood · 2021 to 2026
$1.4M
NIDA NIH HHS P30 DA011041NIDA NIH HHS P30 DA029926NIDA NIH HHS R01 DA054990NIMH NIH HHS T32 MH128395
6 · The paper itself

Abstract

backgroundPeople who inject drugs are disproportionately impacted by SARS-CoV-2 and COVID-19, yet they do not frequently accept vaccination against SARS-CoV-2 when offered.

objectiveThis study aimed to explore why people who inject drugs decline free vaccines against SARS-CoV-2 and how barriers to vaccination can potentially be addressed.

methodsWe conducted semistructured qualitative interviews with 17 unvaccinated adult persons who inject drugs during August and September 2021 at a New York City syringe service program, where approximately three-fourth of participants identified as Latino (55%) or African American (22%). Interviews lasted roughly 20 minutes. The interview guide examined reasons for declining vaccination, participants' understanding of COVID-19 risks, and how messages could be developed to encourage vaccine uptake among people who inject drugs.

resultsParticipants acknowledged that they faced increased risk from SARS-CoV-2 owing to their injection drug use but feared that long-term substance use may have weakened their health, making them especially vulnerable to side effects. Fears of possible side effects, compounded by widespread medical mistrust and questions about the overall value of vaccination contributed to marked ambivalence among our sample. The desire to protect children and older family members emerged as key potential facilitators of vaccination.

conclusionsCommunity-developed messages are needed in outreach efforts to explain the importance of vaccination, including the far greater dangers of COVID-19 compared to possible unintended side effects. Messages that emphasize vaccines' ability to prevent inadvertently infecting loved ones, may help increase uptake. Community-focused messaging strategies, such as those used to increase HIV and hepatitis C virus testing and overdose prevention among people who inject drugs, may prove similarly effective.

Indexed as

barriercommunicationcommunityCOVID-19dangerdrugshesitancyimpactinterviewpeople who inject drugsqualitativeSARS-CoV-2United Statesvaccinationvaccinevaccine hesitancy

Identifiers

PMID35191841
PMCPMC8945077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.